The importance of FLT3 mutational analysis in acute myeloid leukemia

MM Patnaik - Leukemia & lymphoma, 2018 - Taylor & Francis
Activating mutations in FMS-like tyrosine kinase 3 (FLT3), including internal tandem
duplications (ITDs) and tyrosine kinase domain (TKD) mutations, are common in patients …

[PDF][PDF] The importance of FLT3 mutational analysis in acute myeloid leukemia

MM Patnaik - LEUKEMIA & LYMPHOMA, 2018 - kimia-pharma.co
Activating mutations in FMS-like tyrosine kinase 3 (FLT3), including internal tandem
duplications (ITDs) and tyrosine kinase domain (TKD) mutations, are common in patients …

The importance of FLT3 mutational analysis in acute myeloid leukemia.

MM Patnaik - Leukemia & Lymphoma, 2018 - search.ebscohost.com
Activating mutations in FMS-like tyrosine kinase 3 (FLT3), including internal tandem
duplications (ITDs) and tyrosine kinase domain (TKD) mutations, are common in patients …

The importance of FLT3 mutational analysis in acute myeloid leukemia.

MM Patnaik - Leukemia & Lymphoma, 2017 - europepmc.org
Activating mutations in FMS-like tyrosine kinase 3 (FLT3), including internal tandem
duplications (ITDs) and tyrosine kinase domain (TKD) mutations, are common in patients …

The importance of FLT3 mutational analysis in acute myeloid leukemia

MM Patnaik - Leukemia & lymphoma, 2018 - pubmed.ncbi.nlm.nih.gov
Activating mutations in FMS-like tyrosine kinase 3 (FLT3), including internal tandem
duplications (ITDs) and tyrosine kinase domain (TKD) mutations, are common in patients …

The importance of FLT3 mutational analysis in acute myeloid leukemia

MM Patnaik - Leukemia and Lymphoma, 2018 - mayoclinic.elsevierpure.com
Activating mutations in FMS-like tyrosine kinase 3 (FLT3), including internal tandem
duplications (ITDs) and tyrosine kinase domain (TKD) mutations, are common in patients …